A Phase Ib/II, multi-center, open-label study to evaluate the efficacy of AUY922 in combination with Trastuzumab in patients with locally advanced or metastatic HER 2-positive breast cancer, that has progressed after or during at least one

Short title	A Phase Ib/II, multi-center, open-label study to evaluate the efficacy of AUY922 in combination with Trastuzumab in patients with locally advanced or metastatic HER 2-positive breast cancer, that has progressed after or during at least one
Status	Finished
Effective start/end date	1/02/11 → 31/01/15

Project Details